Ginkgo Bioworks Announces Participation in UBS MedTech, Tools and Genomics Summit 2023
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, announced...
United States Bioworks Holdings Inc Bioworks Holdings Across Drug Discovery Molecule Synthesis Genomics Summit
Source: prnewswire.com